MedPath

The PASSAGE Program: a structured multicomponent interdisciplinary group intervention for the self-management of chronic low back pai

Completed
Conditions
Musculoskeletal Diseases
on-specific chronic low back pain
Registration Number
ISRCTN15669062
Lead Sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke (Canada)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
64
Inclusion Criteria

1. Aged 18 years or older
2. Had a medical diagnosis of non-specific CLBP based on recognized criteria.
3. Reported pain of at least moderate intensity (at least 4/10) in the seven days prior to enrolment
4. Were motivated to attend all group sessions and to integrate the proposed self-management strategies
5. Agreed to not introduce new medications or treatments/therapies over the course of the PASSAGE program

Exclusion Criteria

1. Subjects who reported major pain syndromes other than CLBP such as arthritis or life threatening diseases such as cancer
2. Physical/psychiatric disorders that could compromise their participation in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity, measured with a standardized numerical rating scale (NRS)
Secondary Outcome Measures
NameTimeMethod
1. Progress during rehabilitation treatment (Quebec Back Pain Disability Scale)<br>2. Pain interference (Brief Pain Inventory) <br>3. Impact of pain on sleep quality (Chronic Pain Sleep Inventory) <br>4. Pain coping strategies and (Coping Strategy Questionnaire) <br>5. Tendency to catastrophize (Pain Catastrophizing Scale) <br>6. Depressive symptoms (The Beck Depression Inventory) <br>7. Health-related quality of life (SF-12v2) <br>8. Patient global impression of change (PGIC) <br>9. Perceived pain relief (0 to 100% Pain Relief Scale) <br><br>Quantitative data were collected in both study groups at baseline (T0), after the intervention group completed the eight sessions of the PASSAGE Program (T1), and 3 months later (T2).
© Copyright 2025. All Rights Reserved by MedPath